Core Scientific, Inc. (CORZ)
Core Scientific, Inc. (CORZ) Reports Q2 Earnings: What Key Metrics Have to Say
The headline numbers for Core Scientific, Inc. (CORZ) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Core Scientific, Inc. (CORZ) Reports Q2 Loss, Lags Revenue Estimates
Core Scientific, Inc. (CORZ) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.04 per share a year ago.
Core Scientific shareholders push back on CoreWeave's $9B takeover offer: report
CoreWeave (NASDAQ:CRWV)'s $9 billion all-stock acquisition of data center operator Core Scientific (NASDAQ:CORZ) is facing shareholder resistance, with major investors saying they may vote against the deal unless its terms are updated, according to a Financial Times report. The FT, citing people familiar with the matter, said the pushback stems from concerns that the current offer undervalues Core Scientific and exposes its investors to unnecessary downside risk.
Core Scientific shareholders balk at terms of CoreWeave merger offer, FT reports
CoreWeave's $9 billion deal to buy data centre landlord Core Scientific is facing a potential revolt, with some top shareholders of the target company arguing it could leave them short-changed, the Financial Times reported on Tuesday.
Core Scientific: Why Smart Money Is Betting Big On This AI Infrastructure Play
CoreWeave's acquisition of CORZ transforms it into a key AI infrastructure play, locking in power assets and slashing costs for long-term growth. Multi-billion-dollar contracts with OpenAI and Google provide real revenue visibility, shifting CORZ from speculative crypto to high-margin, recurring AI cash flows. Options flow, GEX, and dark pool data all point to bullish institutional sentiment, supporting a structured $15/$20 call spread for risk-defined upside exposure.
CoreWeave: Market Hates A Good Deal
CoreWeave's acquisition of Core Scientific aims to verticalize data center ownership and cut $500 million in costs by 2027. The deal gives CoreWeave direct control over data center assets, enabling faster, tailored AI infrastructure deployments and improved cost efficiency. Despite operational benefits, the market reacted negatively, with CoreWeave shares dropping and the deal value for Core Scientific shareholders declining.
CoreWeave: Core Scientific Buyout Changes Everything
CoreWeave's buyout cuts $10B+ lease costs and secures 1.3 GW+ of owned high-density AI data center capacity. The merger locks $25B+ in 12-year take-or-pay contracts, including milestone OpenAI and IBM deals. CoreWeave's Q1 revenue grew 420% YoY to $981.6M, with $606.1M EBITDA and strong 62% margin expansion.
CoreWeave: Everyone Hates The Core Scientific Deal; We Don't (Rating Upgrade)
We're upgrading CoreWeave back to a buy after its strategic all-stock acquisition of CoreScientific making use of its 300% stock appreciation since IPO. The deal unlocks cost savings, eliminates $10B in future lease overhead, and gives CoreWeave control over 1.3 GW of power capacity. CoreWeave is now buying rather than renting power capacity. Valuation remains premium but has come down since our sell call and is more attractive at current levels.
CoreWeave's $9 Billion Power Play for Core Scientific
AI infrastructure leader CoreWeave, Inc. NASDAQ: CRWV has announced a $9.0 billion, all-stock deal to buy data center operator Core Scientific, Inc. NASDAQ: CORZ.
CoreWeave to acquire Core Scientific in $9 billion all-stock deal
Artificial intelligence cloud infrastructure provider CoreWeave said Monday it plans to buy Core Scientific, a data center infrastructure operator. It is an all-stock deal valued at approximately $9 billion.
CoreWeave acquires data center provider Core Scientific in $9B stock deal
CoreWeave announced Monday that it signed a $9 billion all-stock deal to acquire Core Scientific, a data center infrastructure provider.
Why CoreWeave plans to buy Core Scientific — and why both stocks are dropping
The $9 billion deal is a play on AI power needs, but one analyst thinks the purchase price undervalues Core Scientific's business and potential.
